| Pharmaceutical Information |
| Drug Name |
Rasburicase |
| Drug ID |
BADD_D01917 |
| Description |
Rasburicase is a recombinant urate-oxidase enzyme produced by a genetically modified Saccharomyces cerevisiae strain. The cDNA coding for rasburicase was cloned from a strain of _Aspergillus flavus_. |
| Indications and Usage |
For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy) |
| Marketing Status |
approved; investigational |
| ATC Code |
V03AF07 |
| DrugBank ID |
DB00049
|
| KEGG ID |
D05704
|
| MeSH ID |
C469709
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D08LJP
|
| NDC Product Code |
0024-5151; 0024-5150 |
| UNII |
08GY9K1EUO
|
| Synonyms |
rasburicase | Elitek | Fasturtec |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
134774-45-1 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
